Position in ARGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,647,664
-$232,504 QoQ
Shares Held
25,536
+13.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,208,323 across 186 Biotechnology names. ARGX ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in ARGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,647,664 | 25,536 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,880,168 | 22,451 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,949,573 | 35,183 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,127,857 | 58,285 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,163,102 | 77,996 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,118,040 | 6,696 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $1,657,804 | 3,855 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,877,008 | 12,387 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,039,635 | 7,990 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $35,861,458 | 72,944 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,942,201 | 35,774 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,855,462 | 13,032 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,251,205 | 37,619 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,731,576 | 13,402 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $3,822,414 | 12,657 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,540,729 | 8,439 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,488,365 | 12,667 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,925,995 | 6,549 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $3,618,770 | 16,067 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||